Ameritas Investment Partners, Inc. Kiniksa Pharmaceuticals, Ltd. Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$13.62 - $20.2 $11,113 - $16,483	816 Added 35.82%	3,094 $53,000
Q3 2020 Nov 13, 2020	BUY	$15.21 - $25.53 $9,095 - $15,266	598 Added 35.6%	2,278 $35,000
Q2 2020 Aug 05, 2020	BUY	$15.08 - $26.0 $10,631 - $18,330	705 Added 72.31%	1,680 $43,000
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.39 $5,808 - $8,971	440 Added 82.24%	975 $13,000
Q3 2018 Nov 13, 2018	BUY	$13.23 - $30.93 $7,078 - $16,547	535 New	535 $14,000

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $651M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.